Source: Annual Congress 2003 - Epidemiological aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lindberg, L. G. Larsson, A. C. Jonsson, B. Lundbäck (Luleå, Stockholm, Sweden). 10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria. Eur Respir J 2003; 22: Suppl. 45, 1451

Member's Comments

No comment yet.

Related content which might interest you: Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 External validation of the updated ADO score to predict mortality in COPD patients from the Birmingham COPD cohort Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Population based study on the prevalence of COPD by spirometric criteria Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Prevalence of airflow obstruction according GOLD, ATS and ERS criteria in symptomatic ever-smokers referring to a pulmonary rehabilitation department Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Risk charts of five-year mortality in COPD patients Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020 Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 The effect of changing GOLD severity stage on long-term mortality in COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 GOLD classification of COPD and incident lung cancer: findings from a cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 269s Year: 2004 An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011